risk and prognostic factors for, 178–179
suicide risk in, 179
Substance/medication-induced neurocognitive 
disorder, 591, 603, 627–632
associated features supporting diagnosis of, 630
comorbidity with, 632
development and course of, 631
diagnostic criteria for, 627–629
diagnostic features of, 629–630
diagnostic markers for, 631
differential diagnosis of, 631
functional consequences of, 631
prevalence of, 630
recording procedures for, 629
risk and prognostic factors for, 631
Substance/medication-induced obsessive-
compulsive and related disorder, 235, 236, 
257–260
associated features supporting diagnosis of, 259
diagnostic criteria for, 257–258
diagnostic features of, 259
differential diagnosis of, 259–260
prevalence of, 259
recording procedures for, 258–259
Substance/medication-induced psychotic 
disorder, 89, 110–115
associated features supporting diagnosis of, 113
development and course of, 114